112 related articles for article (PubMed ID: 1099542)
1. [Tests of stimulation of calcitonin secretion. Value in medullary cancer of the thyroid].
Milhaud G; Ribeiro FM; Calmettes C; Taboulet J; Coutris G; Moukhtar MS
Nouv Presse Med; 1975 Jun; 4(24):1793-5. PubMed ID: 1099542
[TBL] [Abstract][Full Text] [Related]
2. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
3. Stimulation tests for diagnosis of medullary thyroid carcinoma.
Sizemore GW; Go VL
Mayo Clin Proc; 1975 Feb; 50(2):53-6. PubMed ID: 1117754
[TBL] [Abstract][Full Text] [Related]
4. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B
Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280
[TBL] [Abstract][Full Text] [Related]
5. Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.
Gharib H; Kao PC; Heath H
Mayo Clin Proc; 1987 May; 62(5):373-8. PubMed ID: 3573825
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
[No Abstract] [Full Text] [Related]
7. Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis.
Graze K; Spiler IJ; Tashjian AH; Melvin KE; Cervi-Skinner S; Gagel RF; Miller HH; Wolfe HJ; DeLellis RA; Leape L; Feldman ZT; Reichlin S
N Engl J Med; 1978 Nov; 299(18):980-5. PubMed ID: 692625
[TBL] [Abstract][Full Text] [Related]
8. Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination?
Machens A; Hauptmann S; Dralle H
J Clin Endocrinol Metab; 2008 Jun; 93(6):2234-8. PubMed ID: 18364379
[TBL] [Abstract][Full Text] [Related]
9. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid.
Emmertsen KK; Nielsen HE; Mosekilde L; Hansen HH
Acta Radiol Oncol; 1980; 19(2):85-9. PubMed ID: 6254339
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of provocative tests in suspected medullary carcinoma of the thyroid:heterogeneity of calcitonin responses to calcium and pentagastrin.
McLean GW; Rabin D; Moore L; Deftos LJ; Lorber D; McKenna TJ
Metabolism; 1984 Sep; 33(9):790-6. PubMed ID: 6472115
[TBL] [Abstract][Full Text] [Related]
11. Is thyrotropin-releasing hormone as reliable a calcitonin stimulant as pentagastrin in medullary thyroid carcinoma?
Ahuja S
Acta Endocrinol (Copenh); 1990 May; 122(5):640-2. PubMed ID: 2112816
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of occult familial medullary carcinoma of the thyroid using pentagastrin.
Starling JR; Harris C; Granner DK
Arch Surg; 1978 Mar; 113(3):241-3. PubMed ID: 637688
[TBL] [Abstract][Full Text] [Related]
13. Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland.
Wells SA; Baylin SB; Linehan WM; Farrell RE; Cox EB; Cooper CW
Ann Surg; 1978 Aug; 188(2):139-41. PubMed ID: 686877
[TBL] [Abstract][Full Text] [Related]
14. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland.
Linehan WM; Farrell RE; Cooper CW; Wells SA
Surg Forum; 1977; 28():110-2. PubMed ID: 617389
[No Abstract] [Full Text] [Related]
15. Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma.
Rude RK; Singer FR
J Clin Endocrinol Metab; 1977 May; 44(5):980-3. PubMed ID: 858780
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroid.
Hennessy JF; Gray TK; Cooper CW; Ontjes DA
J Clin Endocrinol Metab; 1973 Jan; 36(1):200-3. PubMed ID: 4681885
[No Abstract] [Full Text] [Related]
17. Urine calcitonin as a test for medullary thyroid cancer: a new screening procedure.
Silva OL; Snider RH; Moore CF; Becker KL
Ann Surg; 1979 Mar; 189(3):269-74. PubMed ID: 426557
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.
Goltzman D; Potts JT; Ridgway RC; Maloof F
N Engl J Med; 1974 May; 290(19):1035-9. PubMed ID: 4207025
[No Abstract] [Full Text] [Related]
19. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.
Corsello SM; Lovicu RM; Migneco MG; Rufini V; Summaria V
Rays; 2000; 25(2):257-66. PubMed ID: 11370543
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
